文献速递乳腺US

使用多柔比星-金纳米簇-白蛋白纳米生物偶联物对人三阴性和雌激素受体阳性乳腺癌细胞同步进行化疗/光热治疗/声动力治疗

Synchronized Chemotherapy/Photothermal Therapy/Sonodynamic Therapy of Human Triple-Negative and Estrogen Receptor-Positive Breast Cancer Cells Using a Doxorubicin-Gold Nanoclusters-Albumin Nanobioconjugate.
PubMed 文献 · Ultrasound Med Biol · 2024-03-27

研究制备了金纳米簇-牛血清白蛋白(AuNCs-BSA)和多柔比星-AuNCs-BSA(Dox-AuNCs-BSA)纳米生物偶联物,分别作为双光敏剂/声敏剂和三重化疗/光敏剂/声敏剂。AuNCs-BSA光热转换效率为32.9%;两种偶联物在激光照射或超声暴露下被激活,两种辐射联合时效率最高。MTT法显示Dox-AuNCs-BSA对MCF-7和MDA-MB-231乳腺癌细胞的CTX/PTT/SDT协同进展,所需药物剂量更低且肿瘤细胞消融改善。

要点

  • AuNCs-BSA与Dox-AuNCs-BSA的ζ电位分别为-29 mV和-18 mV。
  • AuNCs-BSA光热转换效率为32.9%。
  • Dox-AuNCs-BSA在激光与超声联合时激活效率最高。

核心结论

  • MTT法、细胞内活性氧生成检测和细胞凋亡检测证实,Dox-AuNCs-BSA的CTX/PTT/SDT以更低所需药物剂量实现 improved tumor cell ablation,可能增强治疗效果并克服治疗抵抗。

研究设计与样本

  • 体外研究,制备AuNCs-BSA和Dox-AuNCs-BSA纳米生物偶联物,在人TNBC细胞及MCF-7和MDA-MB-231乳腺癌细胞系中评估;采用MTT细胞增殖试验、细胞内活性氧检测和凋亡检测。

诊断标准与关键数值

  • AuNCs-BSA的ζ电位为-29 mV,Dox-AuNCs-BSA的ζ电位为-18 mV。
  • AuNCs-BSA的光热转换效率计算为32.9%。
  • AuNCs-BSA和Dox-AuNCs-BSA在激光照射或超声暴露下被激活,两种辐射联合时效率最高。
  • MTT细胞增殖试验评估Dox-AuNCs-BSA对MCF-7和MDA-MB-231乳腺癌细胞的CTX/PTT/SDT,发现协同进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Novel strategies for treating triple-negative breast cancer (TNBC) are ongoing because of the lack of standard-of-care treatment. Nanoframed materials with a protein pillar are considered a valuable tool for designing multigoals of energy-absorbing/medication cargo and are a bridge to cross-conventional treatment strategies.

METHODS: Nanobioconjugates of gold nanoclusters-bovine serum albumin (AuNCs-BSA) and doxorubicin-AuNCs-BSA (Dox-AuNCs-BSA) were prepared and employed as a simultaneous double photosensitizer/sonosensitizer and triple chemotherapeutic/photosensitizer/sonosensitizer, respectively.

RESULTS: The highly stable AuNCs-BSA and Dox-AuNCs-BSA have ζ potentials of -29 and -18 mV, respectively, and represent valuable photothermal and sonodynamic activities for the combination of photothermal therapy and sonodynamic therapy (PTT/SDT) and synchronized chemotherapy/photothermal therapy/sonodynamic therapy (CTX/PTT/SDT) of human TNBC cells, respectively. The efficiency of photothermal conversion of AuNCs-BSA was calculated to be a promising value of 32.9%. AuNCs-BSA and Dox-AuNCs-BSA were activated on either laser light irradiation or ultrasound exposure with the highest efficiency on the combination of both types of radiation. CTX/PTT/SDT of MCF-7 and MDA-MB-231 breast cancer cell lines by Dox-AuNCs-BSA were evaluated with the MTT cell proliferation assay and found to progress synergistically.

CONCLUSION: Results of the MTT assay, detection of the generation of intracellular reactive oxygen species and occurrence of apoptosis in the cells confirmed that CTX/PTT/SDT by Dox-AuNCs-BSA was attained with lower needed doses of the drug and improved tumor cell ablation, which would result in the enhancement of therapeutic efficacy and overcoming of therapeutic resistance.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Kayani Z, Heli H, Dehdari Vais R, et al. Synchronized Chemotherapy/Photothermal Therapy/Sonodynamic Therapy of Human Triple-Negative and Estrogen Receptor-Positive Breast Cancer Cells Using a Doxorubicin-Gold Nanoclusters-Albumin Nanobioconjugate. Ultrasound Med Biol. 2024. PMID: 38538442. doi:10.1016/j.ultrasmedbio.2024.02.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。